AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
172 hedge funds and large institutions have $719M invested in Avadel Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 51 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
1% less funds holding
Funds holding: 174 → 172 (-2)
38% less call options, than puts
Call options by funds: $2.43M | Put options by funds: $3.91M
Holders
172
Holding in Top 10
7
Calls
$2.43M
Puts
$3.91M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$11.9M | |
| 3 | +$10.7M | |
| 4 |
TLP
Tri Locum Partners
New York
|
+$8.98M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.67M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$8.62M | |
| 3 | -$8.41M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.34M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.71M |
